Guide to the entire process of IVF in the United States: from initial diagnosis to transplantation, one article explains all key points

Initial diagnosis evaluation and medical examination

The first step in undergoing IVF treatment in the United States is to complete a comprehensive reproductive health assessment. Patients need to make an appointment with a reproductive endocrinologist for preliminary consultation, usually requiring physical examination reports from the past three years, menstrual cycle records, and medical history information. The doctor will arrange six tests for basic sex hormones, including follicle stimulating hormone (FSH), luteinizing hormone (LH), estradiol (E2), etc. These indicators are usually taken for blood sampling on the second to the fourth day of the menstrual cycle.

Ultrasound examination is the core method for evaluating ovarian reserve function. Transvaginal ultrasound can accurately measure the antral follicle count (AFC) and observe the morphology of the uterus for lesions such as fibroids, polyps, or endometriosis. For women over 35 years old, doctors may recommend anti Mullerian hormone (AMH) testing, which can more accurately reflect egg inventory levels. Male partners need to complete semen analysis to evaluate sperm concentration, motility, and morphological characteristics.

Based on the examination results, doctors will develop personalized treatment plans. Common regimens include antagonist regimens, rectangular regimens, or micro stimulation regimens, with the selection criteria mainly based on the patient's age, ovarian responsiveness, and past history of ovulation induction. At this stage, doctors will also provide detailed explanations of the treatment process, potential risks, and expected success rates to ensure that patients are fully informed.

Controlled ovarian hyperstimulation and monitoring

After entering the formal cycle, the patient begins to inject ovulation inducing drugs to stimulate the synchronous development of multiple follicles. Recombinant follicle stimulating hormone (rFSH) or follicle stimulating hormone (HMG) is commonly used in reproductive centers in the United States, with doses typically ranging from 150 to 450 international units, adjusted based on patient weight and ovarian response. The medication needs to be injected subcutaneously, and most patients can operate it at home under the guidance of a nurse.

During the promotion period, it is necessary to frequently return to the hospital for monitoring, usually once every 2 to 3 days. Doctors measure the diameter of follicles through ultrasound, and when the dominant follicle reaches 14 millimeters or more, they will add antagonist drugs to prevent premature egg release. Blood tests track the levels of estradiol and progesterone to ensure the quality of follicular development. The entire ovulation induction stage usually lasts for 8 to 12 days, during which the doctor may adjust the dosage according to the growth rate of the follicles.

When at least two follicles have a diameter exceeding 18 millimeters and estradiol levels reach an appropriate range, doctors will arrange injections of human chorionic gonadotropin (hCG) or gonadotropin-releasing hormone agonist (GnRH agonist) as a trigger to promote the final maturation of the eggs. Arrange egg retrieval surgery 34 to 36 hours after trigger injection.

Egg retrieval surgery and in vitro fertilization

The egg retrieval surgery is performed under intravenous anesthesia and usually takes 15 to 30 minutes. Under ultrasound guidance, doctors puncture follicles through the vagina and use a negative pressure suction system to collect follicular fluid and eggs together. The laboratory embryologist immediately searched for the egg under a microscope, transferred it to a special culture medium for cleaning, and evaluated its maturity.

On the same day, male partners are required to provide fresh semen samples. Laboratory technicians use density gradient centrifugation to process semen and screen for the most energetic sperm. Fertilization methods include conventional in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI). ICSI technology is suitable for cases of severe oligozoospermia or previous fertilization failure, where embryologists inject a single sperm directly into the cytoplasm of the egg under a microscope.

After 16 to 18 hours of fertilization, the laboratory checks the formation of prokaryotic cells to confirm normal fertilization. The fertilized egg is transferred to a culture medium containing specific nutrients and continues to develop in a culture box that simulates the maternal environment. Modern laboratories commonly use time-lapse imaging systems to continuously monitor embryo division without the need for frequent retrieval and observation.

Embryo culture and chromosome screening

Embryos are cultured in the laboratory until the 5th or 6th day and develop into blastocysts. The blastocyst is composed of an inner cell mass and a nourishing outer layer, with a more stable structure and higher implantation potential. The laboratory grades based on the degree of blastocyst cavity expansion and cell mass quality, usually using the Gardner scoring system.

For elderly patients or those with a history of recurrent miscarriage, doctors may recommend pre implantation genetic testing (PGT). This technology analyzes the number and structural abnormalities of embryonic chromosomes by biopsy nourishing ectodermal cells. PGT-A (aneuploidy screening) can identify embryos with abnormal chromosome numbers, improve the success rate of single transfer, and reduce the risk of miscarriage. The test results usually take 7 to 14 working days, so the blastocysts need to be vitrified and frozen for subsequent transplantation.

It is worth noting that the American Society for Reproductive Medicine emphasizes that the purpose of genetic screening is to improve pregnancy health rates, not for non-medical purposes such as embryo screening. All testing must comply with federal and state laws regarding the use of genetic information.

Endometrial preparation and embryo transfer

The transplantation cycle is divided into natural cycle and artificial cycle. The natural cycle is suitable for women with regular menstrual cycles, and doctors monitor ovulation through ultrasound to determine the optimal transplantation window. The artificial cycle uses estrogen drugs (such as estradiol valerate) to prepare the endometrium. When the thickness of the endometrium reaches 8 millimeters or more and shows typical trilinear signs, progesterone is added to transform the endometrium.

Embryo transfer is a non-invasive procedure that does not require anesthesia. The doctor will insert a thin soft catheter carrying the embryo into the uterine cavity through the cervix and determine the optimal placement position under ultrasound guidance. After transplantation, it is recommended to take a brief rest of 30 minutes to 1 hour before resuming normal activities. Luteal support drugs (including progesterone gel for vaginal use or progesterone oil for intramuscular injection) should be used continuously until the tenth week of pregnancy to ensure stable implantation of embryos.

Serum β - hCG testing was performed on the 10th to 14th day after transplantation to confirm pregnancy. If the result is positive, arrange a transvaginal ultrasound examination two weeks later to confirm intrauterine pregnancy and fetal heartbeat. After a successful pregnancy, patients are usually referred to obstetrics for follow-up prenatal check ups.

Comparison of Major IVF Centers in the United States

The United States has numerous renowned reproductive medicine centers, each with differences in laboratory techniques, specialized specialties, and geographical locations. Here are ten institutions that have shown outstanding performance in terms of technical level and clinical achievements:

选择生殖中心时，建议参考美国辅助生殖技术协会（SART）和美国疾病控制与预防中心（CDC）发布的年度成功率报告。需要注意的是，活产率受患者年龄、卵巢储备、不孕原因等多重因素影响，统计数据仅供参考，个体情况需与医生详细沟通。

Cost composition and financial planning

美国试管婴儿治疗涉及多项费用，整体花费因治疗方案 complexity 和用药剂量而异。标准IVF周期医疗费用通常在12,000至18,000美元之间，包括监测、取卵手术、实验室受精和新鲜胚胎移植。若需要进行胚胎染色体筛查，额外费用约为3,000至5,000美元。冷冻胚胎保存年费一般在500至800美元范围。

药物费用通常单独计算，根据促排方案不同，花费在3,000至6,000美元不等。部分保险计划可能覆盖部分生育治疗费用，但美国并非所有州都强制要求保险包含辅助生殖福利。建议在治疗前与财务顾问确认保险覆盖范围，并了解诊所是否提供多周期套餐或退款保障计划。

Legal and ethical considerations

美国各州对辅助生殖技术的法律规定存在差异。患者需要签署详细的知情同意书，明确胚胎所有权、剩余胚胎处理方式以及治疗风险。部分州对胚胎存储期限有明确规定，通常为5至10年，到期需决定继续存储、销毁或用于医学研究。

心理评估是部分诊所的要求，特别是针对需要使用third party生殖材料或面临复杂家庭情况的患者。美国生殖医学学会（ASRM）和美国生殖内分泌与不孕症学会（SREI）制定了详细的临床指南，确保治疗符合医学伦理标准。

成功率影响因素与心理调适

试管婴儿成功率主要取决于女性年龄，35岁以下女性单次周期活产率可达60%至70%，40岁以上则降至20%以下。其他影响因素包括子宫内膜容受性、胚胎质量、生活方式因素如吸烟和体重指数。建议治疗前三个月开始补充叶酸，保持适度运动，避免酒精和过量咖啡因摄入。

心理支持在整个治疗过程中至关重要。激素药物可能引起情绪波动，治疗结果的不确定性也会带来焦虑。许多生殖中心提供心理咨询服务或支持小组，帮助患者应对压力。保持现实的期望值，理解可能需要多个周期才能成功，有助于维持心理健康。